HEIDELBERG PHARMA AG O.N./ DE000A11QVV0 /
| 2024-11-15 7:30:20 PM | Chg. +0.040 | Volume | Bid7:30:24 PM | Ask7:30:24 PM | Market Capitalization | Dividend Y. | P/E Ratio |
|---|---|---|---|---|---|---|---|
| 2.280EUR | +1.79% | 0 Turnover: 0.000 |
-Bid Size: - | -Ask Size: - | 77.92 mill.EUR | 0.00% | - |
Assets
| 2011 IFRS in mill. EUR |
2012 IFRS in mill. EUR |
2013 IFRS in mill. EUR |
2014 IFRS in mill. EUR |
2015 IFRS in mill. EUR |
|||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Property and Equipment | 2.1000 | 2.1000 | 1.3000 | 1.1000 | 1 | ||||||
| Intangible Assets | 4.4000 | 4.1000 | 3.1000 | 2.9000 | 2.9000 | ||||||
| Long-Term Investments | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.0000 | ||||||
| Fixed Assets | 12.8000 | 12.5000 | 12.8000 | 12.1000 | 10 | ||||||
| Inventories | .5000 | .3000 | .0800 | .2000 | .3000 | ||||||
| Accounts Receivable | .2000 | .3000 | .2000 | .2000 | .4000 | ||||||
| Cash and Cash Equivalents | 3.4000 | 23.4000 | 8.9000 | 2.2000 | 1.3000 | ||||||
| Current Assets | 8 | 25.2000 | 9.5000 | 2.9000 | 2.1000 | ||||||
| Total Assets | 20.8000 | 37.7000 | 22.3000 | 15 | 12.1000 | ||||||
Liabilities
| 2011 IFRS in mill. EUR |
2012 IFRS in mill. EUR |
2013 IFRS in mill. EUR |
2014 IFRS in mill. EUR |
2015 IFRS in mill. EUR |
|||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Accounts Payable | 1.4000 | .9000 | .2000 | .3000 | .3000 | ||||||
| Long-term debt | - | - | - | - | - | ||||||
| Liabilities to Banks | 10.5000 | 2.6000 | 2.6000 | 0.0000 | 0.0000 | ||||||
| Provisions | - | - | - | - | - | ||||||
| Liabilities | 25.3000 | 17.8000 | 7.3000 | 3.2000 | 2.6000 | ||||||
| Share Capital | 5.4000 | 7.8250 | 7.8250 | 7.8190 | 9.3060 | ||||||
| Total Equity | -4.5000 | 19.9000 | 14.9000 | 11.9000 | 9.5000 | ||||||
| Minority Interests | - | - | - | - | - | ||||||
| Total liabilities equity | 20.8000 | 37.7000 | 22.3000 | 15 | 12.1000 | ||||||
Income Statement
| 2011 IFRS in mill. EUR |
2012 IFRS in mill. EUR |
2013 IFRS in mill. EUR |
2014 IFRS in mill. EUR |
2015 IFRS in mill. EUR |
|||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenues | 11.7000 | 17.8000 | 19.1000 | 5 | 3.9000 | ||||||
| Depreciation (total) | - | - | - | - | - | ||||||
| Operating Result | -13.4000 | -8.9000 | -5 | -5.6000 | -6.5000 | ||||||
| Interest Income | -.5000 | -.5000 | -.0800 | -.0300 | .0030 | ||||||
| Income Before Taxes | -13.9000 | -9.4000 | -5 | -5.6000 | -6.5000 | ||||||
| Income Taxes | 0.0000 | 0.0000 | 0.0000 | .0900 | .0400 | ||||||
| Minority Interests Profit | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.0000 | ||||||
| Net Income | -13.9000 | -9.4000 | -5 | -5.7000 | -6.6000 | ||||||
Per Share
Cash Flow
| 2011 IFRS in mill. EUR |
2012 IFRS in mill. EUR |
2013 IFRS in mill. EUR |
2014 IFRS in mill. EUR |
2015 IFRS in mill. EUR |
|||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash Flow from Operating Activities | -9 | -5.1000 | -14.5000 | -6.6000 | -4.8000 | ||||||
| Cash Flow from Investing Activities | .6000 | -.2000 | -.2000 | -.2000 | -.2000 | ||||||
| Cash Flow from Financing | 9.8000 | 25.3000 | -.2000 | -.0400 | 4.1000 | ||||||
| Decrease / Increase in Cash | 1.5000 | 19.9000 | -14.4000 | -6.7000 | -.9000 | ||||||
| Employees | 124 | 128 | 92 | 52 | 55 | ||||||
